Incidence of anemia in patients diagnosed with solid tumors receiving chemotherapy, 2010-2013

Clinical Epidemiology

Volumn 8, Issue , 2016, Pages 61-71

  Xu, Hairong ^a   Xu, Lanfang ^b   Page, John H ^a   Cannavale, Kim ^b   Sattayapiwat, Olivia ^b   Rodriguez, Roberto ^c   Chao, Chun ^b  

^a AMGEN INC   (United States)

^b KAISER PERMANENTE   (United States)

^c LOS ANGELES MEDICAL CENTER   (United States)

Author keywords

Anemia; Chemotherapy; Incidence; Solid tumors

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; HEMOGLOBIN; PACLITAXEL;

ADULT; ANEMIA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; COLON CANCER; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISTANT METASTASIS; ELECTRONIC MEDICAL RECORD; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; IRON DEFICIENCY ANEMIA; LUNG CANCER; MACROCYTIC ANEMIA; MAJOR CLINICAL STUDY; MALE; MEGALOBLASTIC ANEMIA; MICROCYTIC ANEMIA; NORMOCHROMIC NORMOCYTIC ANEMIA; OVARY CANCER; RECTUM CANCER; STOMACH CANCER;

EID: 84964880417     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S89480     Document Type: Article

References (18)

1. Schwartz RN. Anemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocols. Am J Health Syst Pharm. 2007;64(Suppl 2):S5-S13; quiz S28-S30.
2. Rodgers GM, Becker PS, Blinder M, et al. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. 2012;10(5):628-653.
3. Dicato M, Plawny L, Diederich M. Anemia in cancer. Ann Oncol. 2010;21(Suppl 7):7167-7172.
4. Wu Y, Aravind S, Ranganathan G, Martin A, Nalysnyk L. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007. Clin Ther. 2009;31(Pt 2):2416-2432.
5. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst. 1999;91(19):1616-1634.
6. Capo G, Waltzman R. Managing hematologic toxicities. J Support Oncol. 2004;2(1):65-79.
7. Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40(15):2293-2306.
8. Harper P, Littlewood T. Anaemia of cancer: impact on patient fatigue and long-term outcome. Oncology. 2005;69(Suppl 2):2-7.
9. Nieboer P, Buijs C, Rodenhuis S, et al. Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study. J Clin Oncol. 2005;23(33):8296-8304.
10. Cella D, Kallich J, McDermott A, Xu X. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol. 2004;15(6):979-986.
11. Leyland-Jones B, Semiglazov V, Pawlicki M, et al. Maintaining normal hemoglobin levels with epoetin α in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol. 2005;23(25):5960-5972.
12. Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003; 362(9392):1255-1260.
13. Smith RE Jr, Aapro MS, Ludwig H, et al. Darbepoetin α for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. J Clin Oncol. 2008;26(7):1040-1050.
14. Wright JR, Ung YC, Julian JA, et al. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol. 2007;25(9):1027-1032.
15. Juneja V, Keegan P, Gootenberg JE, et al. Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer. Clin Cancer Res. 2008;14(11):3242-3247.
16. Xu H, Kaye JA, Saltus CW, Crawford J, Gasal E, Goodnough LT. Blood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agents. Expert Rev Hematol. 2014;7(5):617-633.
17. Koebnick C, Langer-Gould AM, Gould MK, et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J. 2012;16(3):37-41.
18. Shemin D, Rittenberg D. The life span of the human red blood cell. J Biol Chem. 1946;166(2):627-636.